I believe the estimate was about $80-100k per patient. It might be difficult breaking out the trial costs. I am sure there may be other trial costs (remember all those two dozen collaborations that we are paying for) specific to PIII. Also, the cost per patient is over the course of a long window of time. It may be an impossible task without certain variables the company refuses to release.